UnicyciveUNCY
NASDAQ制药
US$4.79-6.89%
关键指标
$181.96M市值
US$11.0052 周最高
US$3.7152 周最低
519,92730 日均量
22 员工数25.24M 流通股本上市日期 2021-07-13
下次财报 ~2026年5月5日
关于 Unicycive
Unicycive Therapeutics Inc是一家临床阶段的生物技术公司，专注于识别、开发和商业化以解决未满足医疗需求的疗法，主要侧重于肾脏疾病。公司正在推进两个关键产品候选药物：碳酸亚镧（OLC），一种用于治疗慢性肾病透析患者高磷血症的磷酸盐结合剂；以及UNI-494，一种用于治疗急性肾损伤的候选药物。
最新新闻
展示全市场股票新闻
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
What history says about longer-term bond yields after the first Fed hike
How The Fed Has Been Quietly Tightening Ahead Of The Expected Rate Hike
Euro: 1.150 target nears on Fed risk against US Dollar – ING
WTI falls near $100 as Saudi adds Oman route, US stocks surge
相关股票制药 行业
想看 UNCY 的实时 AI 观点?
启动实时多智能体分析室 — Claude、GPT、Gemini、DeepSeek、Grok 和 Qwen 同时分析 UNCY,实时输出信号。